LOADINGLoading your Pro surface...
Tocotrienols differ from tocopherols by having an unsaturated isoprenoid side chain (3 double bonds vs saturated in tocopherols): (1) This unsaturation allows deeper penetration into cell membranes — explaining 40-60x greater in-membrane antioxidant potency; (2) Tocotrienols induce degradation of HMG-CoA reductase protein (post-transcriptional) — this is DIFFERENT from statins (which competitively inhibit the enzyme). Tocotrienols cause the enzyme to be destroyed; (3) Tocotrienols activate caspase-mediated apoptosis in cancer cells via death receptor (DR5) upregulation — a pathway tocopherols don't trigger; (4) NF-κB inhibition by blocking IKK activation; (5) VEGF suppression (anti-angiogenic — relevant for tumor growth inhibition).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.